The scientists at BSRC “Alexander Fleming” perform cutting-edge research, aiming to understand molecular mechanisms of complex biological processes in health and disease. We are also committed to contribute to innovation in medicine, by developing novel therapeutic and diagnostic methods, focusing on immunity and inflammation, cancer, and neurodegenerative diseases. To keep our focus on top-notch research, we recruit at all levels with excellence as the sole criterion and we support our researchers by providing state-of-the science infrastructures and a pleasant working environment. FLEMING is a non-profit organization operating under the auspices of the Greek General Secretariat for Research & Technology and is supported by the Greek government and by national, European and international grants.
Fleming Researcher Dr Antigone Dimas has been awarded an ERC Starting Grant to explore the complex biological impact of dietary intake in humans. This is the fourth ERC grant awarded to a Fleming Researcher in the past 5 years. The title of Dr Dimas's grant is "A genomics and systems biology approach to explore the molecular signature and functional consequences of long-term, structured fasting in humans”.
Recent work by Fleming researchers uncovered a protein methylation-dependent control mechanism in the pathogenesis of pulmonary fibrosis. Pubmed
Seminar 21/11/2016, 12.00. "Chemical biology at EMBL: transforming basic research into drugs", Joe D. Lewis, PhD, Director of the Chemical Biology Core Facility, EMBL, Heidelberg.
Seminar 18/11/2016, 12.00. "Biological imaging in new light: advances in fluorescence and optoacoustic imaging", Prof. Vassilis Ntziachristos, Director of Biological and Medical Imaging, Helmholtz Zentrum, TUM School of Medicine, Munich, Germany.